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Background: The neglected tropical diseases, echinococcosis, schistosomiasis and toxoplasmosis are all globally
widespread zoonotic diseases with potentially harmful consequences. There is very limited data available on the
prevalence of these infections, except for schistosmiasis, in underdeveloped countries. This study aimed to
determine the seroprevalence of Echinococcus multilocularis, Schistosoma mansoni, and Toxoplasma gondii
antibodies in populations from the Monduli and Babati districts in Tanzania.
Methods: A total of 345 blood samples were collected from 160 and 185 randomly selected households from
Babati and Monduli districts, Tanzania between February and May of 2012 and analyzed them using the enzyme
linked immunosorbent assay. The antibodies were determined using the NovaLisa® Toxoplasma gondii IgG,
NovaLisa® Schistosoma Mansoni IgG, NovaLisa® Echinococcus IgG and NovaLisa® Toxoplasma gondii IgM kits
(Novatec, Germany).
Results: The seropositivity estimated for E. multilocularis, S. mansoni, and T. gondii IgG was 11.3% (95% confidence
interval (CI): 7.96 - 14.6), 51.3% (95% CI: 46.0 - 56.5), and 57.68% (95% CI: 52.5 - 62.9), respectively. The seropositivity
for T. gondii IgM was 11.3% (95% CI: 7.96 - 14.6). Living in the Monduli district was found to be the main risk factor
for IgG seropositivity for both schistosomiasis (OR =1.94; 95% CI: 1.23 - 3.08; p =0.005) and toxoplasmosis (OR =2.09;
95% CI: 1.31-3.33; p =0.002).
Conclusions: These results suggest that restricting disease transmission, implementing control measures, and
introducing training projects to increase public awareness are imperative, particularly for the Monduli district.
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Parasitic infections are common in developing countries
due to poor sanitation and inadequate personal hygiene.
Undiagnosed and untreated parasitic infections can have
severe consequences. Furthermore, many parasitic infec-
tions can persist for decades and result in significant
morbidity and mortality. Diseases such as echinococcosis,
schistosomiasis, and toxoplasmosis are globally widespread,* Correspondence: lauyeeling@um.edu.my
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unless otherwise stated.and except for schistosomiasis there is little data on
the prevalence in most developing countries, including
Tanzania.
Echinococcosis is a zoonotic disease caused by metaces-
todes of Echinococcus granulosus, E. multilocularis, E.
vogeli, and E .oligarthrus [1,2]. The larvae invade through
the intestines and establish in distinct organs of the body;
the liver is the most common organ affected, followed by
the brain and muscles [3]. Transmission of Echinococcus
relies on carnivores feeding on infected herbivores, thus a
human infection is usually a dead end for the parasite, as
it does not result in further transmission. In humansd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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fection is confirmed by serological examination, because
infected humans do not discharge Echinococcus eggs [2,4].
The two most medically relevant species, E. granulosus
and E. multicularis, cause human cystic echnicoccosis (CE)
and alveolar echinococcosis, respectively. CE contributes to
more than 95% of the 2–3 million cases reported world-
wide and 600,000 disability adjusted life years, while human
alveolar echinococcosis gives rise to 0.3 - 0.5 million re-
ported cases worldwide [5]. CE due to E. granulosus occurs
on a global scale and is endemic in the Meditarranean,
Central Asia, Northern and Eastern Africa, Australia, and
South America [6,7]. The genetically similar E. multicularis
causes alveolar echinococcosis in the northern hemisphere,
specifically in China, Russia, Europe, and North America
[8]. The existing data on CE in Africa is insufficient and out
of date; therefore a complete picture of the epidemiological
situation cannot be achieved.
Schistosomiasis, or bilharzia, caused by flukes of the
genus Schistosoma, is one of the most common neglected
tropical diseases. This parasite infects approximately 240
million people in 74 countries worldwide [9]. More than
90% of these cases are reported in Sub-Saharan Africa,
where they have reported 200,000 deaths per year [10].
According to the World Health Organization in 2006,
schistosomiasis and soil-transmitted helminthiasis contrib-
utes to more than 40% of all the tropical diseases, not in-
cluding malaria. Furthermore, health statistics report that
fewer than 5% of infected individuals are receiving prazi-
quantel, an affordable anti-helminthic drug [11].
Toxoplasma gondii is an Apicomplexa parasite that in-
fects a majority of bird and mammal species; however, fe-
lines are the only host that excretes the oocyst. Humans
can become integrated into the life cycle of the parasite as
an intermediate host either congenitally or post-natally by
ingesting contaminated food or water, or an infected tissue
cyst [12-15]. Congenitally infected individuals may experi-
ence neurological and vision defects as a result of infection.
In post-natally infected immunocompromised patients T.
gondii can cause chronic infections with symptoms such
as retinochoroiditis, encephalitis, myocarditis, and hepa-
titis [16,17]. In immunocompetent patients, post-natal in-
fections are usually asymptomatic, however, there can be
exceptions that result in severe systemic illness. Globally,
more than 2 billion people have been infected with this
parasite [18]. Interestingly, the prevalence of T. gondii
infection varies geographically as 6.7% of the Korean
population is infected [19], 12.3% of the Chinese [20],
23.9% of the Nigerian [21], 46% of the Tanzanian [22]
and 47% of the population in the underdeveloped areas
of France [23].
Echinococcosis, schistosomiasis, and toxoplasmosis pose
a serious public health issue worldwide because there are
no commercially available vaccines and currently, treatmentdepends on chemical drugs [24-26]. The objective of the
present study was to investigate the E. multilocularis, S.
mansoni, and T. gondii seroprevalence in the populations
of the Babati and Monduli districts. The results provide a
foundation to execute control strategies against these dis-
eases in this province and elsewhere.
Methods
Study area (Babati district)
Babati district is a district of Manyara Region of Tanzania,
East Africa. The administrative capital of the district is
Babati town, 172 km south of Arusha. The district covers
an area of 6,069 km2, a large proportion (640 sq km) of
which is covered by the water bodies of Lake Babati, Lake
Burunge and Lake Manyara. The district is bordered to
the north by Arusha Region, to the southeast by Simanjiro
District, to the south by Dodoma Region, to the southwest
by Hanang District, and to the northwest by Mbulu
district.
Geographical and climatic information
Babati district is located below the Equator between lati-
tude 3° and 4° South and longitude 35° and 36° East. It
has two periods of rain, the low rainfall period, which
lasts from October to December, and high rainfall period
which begins in March and ends in May. The climate
zones observed are tropical and temperate with the aver-
age temperature ranging between 17-27°C.
Main income resource and population
About 90% of the population of Babati District live in
the rural areas and depend on agriculture and livestock
for their livelihood. Mixed crop-livestock, mostly maize-
based system are widely found in the district that are
intercropped with varying species, such as common beans,
pigeon peas and sunflowers, depending on altitude and
availability of rainfall.
According to the national census of 2012, the district
has a population of 312,392 people. Only 44% of the 96
villages have health facilities, such as dispensaries or
health centers, whereas other villages are covered by the
mobile and outreach services, especially for mother and
childcare.
Monduli district
Monduli District is one of the five districts of the Arusha
Region of Tanzania. It is located in the northeastern sec-
tion of the country. It is bordered to the north by Kenya,
to the east by the Kilimanjaro Region and Arumeru
District, to the south by the Manyara Region and to the
west by Ngorongoro District and Karatu District. The
town of Monduli is the administrative seat of the district.
According to the Tanzania National Census of 2012, the
population of Monduli District is 158,929 people and the
Table 1 General characteristics of the participants from




















Mto wa mbu 54 (15.7)
Losirwa 103 (29.9)
Esilelia 28 (8.1)
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from 500 mm to 1000 mm per year. The district possesses
rich wildlife resources that give a potential for tourism ac-
tivities and acts as a source of income for the country.
The people that reside in the Monduli District are the
Maasai people, known to be nomads who practice sheep-
herding as their occupation. The major economic activ-
ities are crop production and livestock keeping, however,
livestock keeping is more dominant. Monduli District has
one hospital, one health centre, and 22 dispensaries.
In parallel with a study of seroprevalence of spargano-
sis among inhabitants of the two districts (Babati and
Monduli); This study was conducted to determine the
seroprevalence of Schistosomia mansoni, Echinococcus
multilocularis and Toxoplasma gondii antibodies among
the inhabitants of the two districts (Babati aand Monduli)
in Northern Tanzania for which the prevalence of these
diseases has not been reported before in these districts.
A cross-sectional study was carried out among inhabi-
tants in Babati and Monduli districts. The villages which
are saved by the health facility were randomly selected.
The participants were randomly selected from outpatient
in the health center and were grouped according to the
villages they belonged to and only one participant was
selected from each household to participate in the study.
Approximately 4 ml of venous blood was collected from
each participant using vacutainers and the serum was pipet-
ted into cryogenic vials which was then stored at −20°C.
A total of 345 blood samples were collected from 160
and 185 randomly selected households from Babati and
Monduli districts, respectively, from three different wards
in each of the districts between February and May of 2012
(Table 1).
The ethical approval to use these samples specifically
for this entire study was obtained from the National In-
stitute for Medical Research (NIMR), an institution
under the Ministry of Health and Social Welfare,
Tanzania. It is the sole institution in the country, re-
sponsible for ethical approval of all research involving
human and human material. The National Institute for
Medical Research gave ethical approval (Ref: NIMR/HQ/
R.8a/VOL.IX/1285) for serological studies on Spirometra
(unpublished data) and co-infections with echinococco-
sis, schistosomiasis and toxoplasmosis, from the 4 ml of
blood taken from each volunteer. Respective health and
government authorities at regional and district level re-
ceived copies of the ethical approval as required for the
implementation of the study. At the individual level, a
written consent was sought after detailed explanation of
the purpose and the benefits of the study. Participants
were informed that their participation was totally vol-
untary and that they were free to participate or not to
participate to the study without giving any reason
whatsoever. Written and signed or thumb-printedconsents were obtained from all participants before
were involved in the study. In case of the minors or
children involved in the study, the next of kin, carer or
guardian on behalf signed or thumb-printed the con-
sent form. The samples were sent to the Department of
Parasitology, Department of Medicine, University of
Malaya, Malaysia in April 2013.
Serology
The NovaLisa® Toxoplasma gondii IgG, NovaLisa®
Schistosoma Mansoni IgG, NovaLisa® Echinococcus
IgG and NovaLisa® Toxoplasma gondii IgM kits (Novatec,
Germany) were used in this study. The sensitivity of the
respective kits is as follows: 96.6%, 87%, 95% and 95.8%
whereas the specificity of aforementioned kits is 98.2%,
95%, 95% and 98%. The analysis was performed in Depart-
ment of Parasitology, University of Malaya. Statistical
analysis was performed using SPSS v.20 (SPSS IBM,
New York, U.S.A). A Pearson’s Chi-square (χ2) test was
used to test the association between categorical vari-
ables and Post –Hoc analysis was performed on statisti-
cally significant variables to explore the association
between the variables of interest. Odd ratios (ORs), rela-
tive risk (RR) and 95% confidence interval (95% CI)
were calculated, furthermore, logistic regression was
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the potential confounding effect. A. The level of statis-
tical significance was set at p <0.05 for each test. Prior
to analyzing, the data was stratified according to districts
(Babati, Monduli), wards (Mamire, Galapo, Magugu,
Mtowambu, Losirwa, Esilelia), gender (male/female) and
age group (1–15, 16–30, 31–45, 46–60, 61–75, 76–90, >91)
in years.
Results
The general characteristics of participants according to
age, gender, district and divisions are shown in Table 1.
Seroprevalence of echinococcosis
Among the 345 serum samples tested, 39 (11.3%, 95%
CI =7.96-14.6) were positive for Echinococcus multilocularis
antibodies. Univariate analysis was performed to check
the association of positive results with gender, age group
and district (Table 2). There was no statistically signifi-
cant association detected with either one of the vari-
ables being tested. However, association tested among
the wards of both districts (Table 3) showed that there
was a significant difference between the wards of Babati
district (p value <0.01). Post-hoc analysis showed that
there is a significant difference between Mamire and
Gelapo (p =0.01, 95% CI 0.101-0.473) as well as Mamire
and Magugu (p =0.03, 95% CI =0.0774-0.439). Logistic re-
gression analysis could not detect any significant associationTable 2 Univariate analysis for the association between risk f
Risk factor Echinococcosis Schistosomiasis
N/Total (%)
Gender
Male 19/136 (13.9) 65/136 (47.8)
Female 20/209 (9.56) 112/209 (53.6)
RR 1.46 0.892
(95% CI) (0.810-2.633) (0.718-1.107)
P-value 0.207 0.293
District
Babati 18/185 (9.73) 109/185 (58.9)
Monduli 21/160 (13.1) 68/160 (42.5)
RR 0.962 1.400
(95% CI) (0.891-1.04) (1.13-1.74)
P-value 0.321 0.002
Age group
≤60 35/317 (11.0) 164/317 (51.7)
>60 4/28 (13.3) 13/28 (46.4)
RR 0.773 1.114
(95% CI) (0.296-2.02) (0.738-1.68)
P-value 0.603 0.590between echinococcosis- positive IgG and the examined
variables (Table 4). The chi-square results for the distribu-
tion of positive IgG and IgM (only T. gondii) results ac-
cording to age groups are shown in Table 5.
Seroprevalence of schistosomiasis
ELISA results showed 177 (51.3%, 95% CI =46.0-56.5)
positive samples out of 345 serum samples for Schistosoma
mansoni antibodies. Statistical analysis (Table 2) demon-
strated that a significantly higher prevalence of schisto-
somiasis in Monduli as compared to Babati (RR =1.40,
95% CI =1.13-1.74). Univariate tests between the wards of
Monduli (Table 3) revealed that there is a significant dif-
ference in the prevalence of schistosomiasis between the
divisions (p =0.03). Post-Hoc analysis showed significant
difference among two of the divisions, Losirwa and Mto
Wa Mbu (p =0.004, 95% CI =0.0714-0.486). Binary logistic
regression also yielded the same pattern of results for dis-
tricts (OR =1.94, 95% CI =1.23-3.08) and for the other
two variables (Table 4).
Seroprevalence of toxoplasmosis
Out of the 345 serum samples, 199 (57.68%, 95% CI =52.5-
62.9) were positive for Toxoplasma gondii IgG antibodies.
A Pearson’s Chi-square (χ2) test (Table 2) showed a stat-
istical significant difference between the occurrence of
infection among the two districts (RR =1.57, 95% CI =1.22-
2.01). Multivariate analysis also indicated that district wasactors and seroprevalence
Toxoplasmosis IgG Toxoplasmosis IgM
71/136 (52.2) 17/136 (12.5)




123/185 (66.5) 16/185 (8.65)




187/317 (59.0) 36/317 (11.3)




Table 3 Univariate analysis for the association between the divisions of districts and seroprevalence
Location Echinococcosis Schistosomiasis Toxoplasmosis IgG Toxoplasmosis IgM
N/Total (%)
Babati wards
Mamire 15/47 (31.9) 26/47 (55.31) 22/47 (46.8) 8/47 (17.0)
Galapo 1/31 (3.22) 12/31 (38.7) 10/31 (32.2) 6/31 (19.3)
Magugu 5/82 (6.09) 30/82 (36.5) 44/82 (53.6) 9/82 (10.9)
P-value 0.000 0.106 0.127 0.441
Monduli wards
Mto wa Mbu 7/54 (12.9) 23/54 (42.6) 37/54 (68.5) 2/54 (3.70)
Losirwa 10/102 (9.80) 71/102 (69.6) 62/102 (60.8) 10/102 (9.80)
Esilelia 1/29 (3.44) 15/29 (51.7) 24/29 (82.7) 4/29 (13.8)
P-value 0.382 0.03 0.081 0.248
Khan et al. Parasites & Vectors 2014, 7:505 Page 5 of 9
http://www.parasitesandvectors.com/content/7/1/505the most important factor, with the samples from Monduli
having higher seropositivity (OR =2.09, 95% CI =1.31-3.32).
As for T. gondii IgM, only 39(11.3%, 95% CI =7.96-14.6)
serum samples were positive. Univariate (Table 2) and
multivariate analysis (Table 4) did not give any statistically
significant results for any of the variables being tested.Discussion
The antibody detection methods are not 100% specific
and sensitive, thus the findings of this study should be
interpreted with caution. Furthermore, the specificity
and sensitivity of the detection methods depend on the
antigen used when performing ELISA. The use of clin-
ical diagnosis for positive cases would have elucidated
even more information regarding the prevalence of these
infectious diseases. However, this could not be accom-
plished in this study due to lack of manpower and the
required expertise in the sampling site to carry outTable 4 Multivariate analysis for the association between risk
Risk factor Echinococcosis Schistosomia
Adjusted OR (95% CI)
Gender
Male/Female 1.40 (0.673-2.927) 1.01 (0.627-1.6
P-value 0.365 0.957
District
Babati/Monduli 0.811 (0.395-1.662) 1.94 (1.227-3.0
P-value 0.567 0.005
Age
≤60/>60 0.915 (0.287-2.910) 1.04 (0.462-2.3
P-value 0.880 0.923clinical test. Despite this, the pattern observed helps to
access the prevalence in a population.
We detected 11.5% (8.00 - 14.6) seroprevalence among
the samples tested. The antigens used cannot differenti-
ate between E. granulosa and E. multilocularis anti-
bodies. However, because alveolar echinococcosis is
prevalent in the Northern hemisphere and cystic echino-
coccosis is endemic in Sub-Saharan Africa [7], E. granu-
losa could be responsible for the seroprevalence
detected but this should be confirmed with clinical tests.
Our result reveals a far greater infection rate than the
0.007% reported in Burkina Faso [27], 0.3 - 0.8% in cen-
tral Sudan [28], and the 2% and 3.5% among Bouya and
Topasa populations, respectively, in southern Sudan
[29]. The only two countries that are well researched are
Kenya and Sudan. In Nigeria, sonar scan results depicted
a prevalence of 5.1% [30]. The IgG antibodies can be de-
tected in patients that are currently in the asymptomatic
phase [31], which could be the reason for the highfactors and seroprevalence
sis Toxoplasmosis IgG Toxoplasmosis IgM
39) 0.958 (0.589-1.557) 1.02 (0.487-2.122)
0.861 0.966
78) 2.09 (1.310-3.326) 0.557 (0.271-1.148)
0.002 0.113
46) 1.56 (0.689-3.551) 1.25 (0.345-4.543)
0.285 0.732
Table 5 Chi-square for age groups
Age groups (years) N (%) Echinococcosis Schistosomiasis Toxoplasmosis IgG Toxoplasmosis IgM
1-10 9 (2.6) 1 (0.3) 4 (1.2) 8 (2.3) 0 (0.0)
11-20 54 (15.7) 1 (0.3) 32 (9.3) 35 (10.1) 6 (1.7)
21-30 80 (23.2) 10 (2.9) 45 (13.0) 48 (13.9) 9 (2.6)
31-40 70 (20.3) 9 (2.6) 33 (9.6) 39 (11.3) 6 (1.7)
41-50 63 (18.3) 10 (2.9) 32 (9.3) 37 (10.7) 8 (2.3)
51-60 41 (11.9) 4 (1.2) 18 (5.2) 20 (5.8) 7 (2.0)
>60 28 (8.1) 4 (1.2) 13 (3.8) 12 (3.5) 3 (0.9)
Total (%) 345(100) 39 (11.3) 177 (51.3) 199 (57.7) 39 (11.3)
χ2 6.75 3.98 8.88 3.16
P-value 0.344 0.680 0.180 0.788
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cificity issues in the enzyme linked immunosorbent assay
(ELISA) can lead to cross-reactions with other species of
Echinococcus or with cysticercosis and give false positive
results [1]. Finally, IgG antibody production is dependent
on many factors such as size, number, surface antigen
orientation, and the condition of the hydatid cysts [2]. No
antibody production has been observed due to the pres-
ence of small cysts, intact cysts, or calcified cysts [32].
The incidence of cystic echinococcosis is not uniformly
distributed in Sub-Saharan Africa. Overall, rates of infec-
tion are higher in the arid regions of Sahel and in eastern
and southern Africa where the household income primar-
ily depends on livestock husbandry. Rates of infection are
less frequent in areas with adequate rainfall in western
and central Africa where livestock is limited [7]. The dif-
ference in infection rates could be due to the fact that the
governing bodies place low importance on the dry pastoral
areas because they contribute little to the gross domestic
product. Sub-Saharan Africa is at the bottom of the list in
terms of contribution to world economics, therefore, the
majority of the area is underdeveloped, and rural areas are
a significant risk factor for cystic echinococcosis [2,33].
Age can be another risk factor [33,34], but in the present
study age did not have a significant effect. Another risk
factor for echinococossis is a high prevalence of hydatido-
sis in livestock and not de-worming the animals [35].
One of the main occupations in Babati and Monduli is
livestock keeping, which may also increase their risk of
disease [36,37]. We observed a significant difference in
the seroprevalence among the Babati wards which could
be due to unhygienic conditions, genetic predisposition,
malnutrition-related immunosuppression [38], close con-
tact with dogs, and a high number of infected livestock.
Schistosoma haemotobium and S. mansoni cause urogeni-
tal schistosomiasis and intestinal schistosomiasis, respect-
ively, and in Africa they contribute more to mortality rate
than other species [39]. Globally, the prevalence of these
parasites tends to increase due to man-made lakes,construction of dams, and irrigation projects. Civil wars
also increase prevalence, because they are one of the pri-
mary reasons for migration [39,40]. Tanzania has the sec-
ond highest prevalence of schistosomiasis in Africa,
coming just behind Nigeria [39,41]. The water supply pro-
jects initiated in the late 1970’s have been blamed for the
transmission of the parasite because they provide a suit-
able habitat for the intermediate host, snails, which pro-
mote the spread of disease [42-46]. Schistosoma mansoni
are rarely present in the coastal regions because of ther-
mal exclusion and because there is no intermediate host
[47]. The potential host candidates for S. mansoni are
Biomphalaria choanomphala, B. pfeifferi, B. sudanica, and
B. angulosa [39,48]. Biompharlaria choanomphala is con-
fined to large bodies of water and hydro-electrical dams in
the south and east-south of the country, whereas B. suda-
nica is found in dams, on the southern shores of Lake
Victoria, and in the north [42]. Biomphalaria pfeifferi is
widely distributed in seasonal water sources and swamps
throughout the majority of Africa, whereas B. angulosa is
primarily observed in swamps only in the southern high-
lands [39,47,49]. In 2012, the prevalence of schistosomiasis
was estimated to be 51.5% [50]. The present study con-
firms this estimate (51.3%). A large number of intermedi-
ate hosts may explain the high seroprevalence observed in
this study.
In S. mansoni endemic places, once the immigrants
are exposed to the parasite, they also tend to show the
same age-pattern as of the residents in terms of infection
[51]. Children under 15 years old are the most prone to
S. mansoni infection, but it does affect people of all age
groups [47,48]. The high infection rate in children under
15 could be due to a more frequent contact with water,
or it could be due to the development of immunity in
adults that lowers prevalence in older populations [52].
However, our results can be explained by high occupa-
tional contact or the use of contaminated water for
household work [53]. We observed a significant differ-
ence between the districts and between the Monduli
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there is a significantly higher infection rate in the Monduli
district compared to Babati. In regards to the wards, our
results reveal a higher seroprevalence in the Losirwa ward
than in Mto wa Mbu. Several socio-epidemiological fac-
tors such as population movement, distance from origin
of disease, urbanization, employment status, cleanliness,
and the level of fecal contamination in the water supply
could explain the high transmission of schistosomiasis in
these areas. There is also an increased susceptibility to in-
fection if one handles snails or practices fishing, farming,
bathing, and swimming in contaminated water bodies.
Over the course of a T. gondii infection, IgM anti-
bodies are typically the first class of antibodies present
in primary response, and they also subside more quickly
than IgG antibodies [54]. The most common serological
marker to diagnose a recently acquired infection is to
measure the specific IgM antibodies [55]. In this study,
the seroprevalence of T. gondii IgM antibodies was 11.3%,
which demonstrates that most infections are not acute,
and thus the IgM antibody titer is too low to be detected.
Another way to distinguish between an acute and a past
infection is by using the IgG avidity test. The most con-
venient and widely used methods to diagnose T. gondii in-
fection is by measuring the IgG antibodies through Sabin-
Feldman dye test, ELISA, Indirect immunofluorescent
assay (IFA) and the modified direct agglutination test [56].
The seroprevalence of T. gondii IgG antibodies in this
study demonstrate that the residents of Monduli and
Babati experience a high exposure to T. gondii. Our study
found 57.7% prevalence of T. gondii, which is higher than
a study carried out in the Tanga district that reported a
seroprevalence of 45.7% [22]. Other Tanzanian studies re-
port 35.0% prevalence in Dar es Salaam [57], and a high
seroprevalence of 72.2% was reported among the Hadzabe
in the northern region of the country [58]. The seropreva-
lences reported by the present study are similar to several
studies performed on exposed groups in Africa. For ex-
ample, seroprevalences of 52.4% and 42.6% were reported
among slaughterhouse workers in Egypt and Djibout, re-
spectively [59,60]. Similarly, studies in Congo yielded 41.9%
seroprevalence in cattle breeders and slaughterhouse em-
ployees [61], whereas in Gezira Province, Sudan, 41.7% of
pregnant women were seropositive [62].
Our findings did not concur with patterns of reduced
seroprevalence among older populations that had been
observed in studies carried out in Nigeria and Congo
[61,63]. This trend was not observed in this study, which
could be due behavioral differences in the societies. We
found no statistical difference in seroprevalence between
males and females (Table 2), however other studies have
suggested that gender does influence exposure or immune
response towards T. gondii [61,64]. The lack of difference
in the antibody count between the two genders in ourstudy could be due to similar everyday activities in which
the individual is exposed to the parasite, which as a result
does not make one gender more prone to the parasite that
the other. We observed a difference in seroprevalence be-
tween the Monduli and Babati districts, which implies that
factors that influence the high infection rate in Monduli
are not present in the Babati district. These factors may
include consumption of contaminated water, fruits, and
undercooked meat [65-67]. Eating raw and undercooked
meat is still practiced in some areas of Tanzania [68].
Conclusion
The lack of sufficient information regarding zoonotic
disease could be a result of ineffective public education
and a lack of communication between veterinary and
human health professionals. Insufficient information pre-
vents the people from taking precautionary measures,
which in turn lead to an increased risk of infection. In fu-
ture studies, the surveys used should have more depth to
gain information regarding the socioeconomic status of
the individuals being used in the study. Our findings show
that there is a higher percentage of S. mansoni and T. gon-
dii infections in the Monduli district as compared to the
Babati district. In terms of the wards of the Monduli dis-
trict, Losirwa has a higher risk of infection to the S. man-
soni parasite as opposed to the Mto Wa Mbu ward. This
suggests that there is a pressing need to improve educa-
tion about the risk factors and prevention methods, espe-
cially in the Monduli district, which could result in a
significant reduction in disease transmission.
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